The Gamma Knife goes to work in Paris
A major public hospital has become the first in Paris to be equipped with a Gamma Knife, the device that enables the surgeon to operate on the brain with no blade or blood involved.
Neurology
Early warning system for Alzheimer's disease
Scientists at the University of Strathclyde in Glasgow are developing a technique based on a new discovery which could pave the way towards detecting Alzheimer’s disease in its earliest stages - and could help to develop urgently-needed treatments.
Treatment options for atrial fibrillation to prevent a stroke
Neurocardiology – especially atrial fibrillation (AF) – was the key topic during a press conference held during the 55th Annual Congress of the Germany Society for Clinical Neurophysiology and Functional Imaging (DGKN) this March. For good reason: Worldwide, there are around six million AF sufferers -- and it is one of the most common causes of stroke because this cardiac irregularity can…
MRI - Aiming to crack the human brain code
The Netherlands - In a very crowded train station, why can you immediately recognise the face of a friend? Professor Rainer Goebel wants to find out. Thanks to €10 million in funding from the country’s Limburg Province, the Brains Unlimited project at Maastricht University will install three high-field magnetic resonance imaging scanners that will allow Prof. Goebel to search for an…
Epilepsy In Our Time
Today’s first European Epilepsy Day sees the launch of Epilepsy In Our Time, an exploration of the lives of five people living with epilepsy across Europe today, through their own video diaries. Lloyd, Marion, Monica, David and Julie invite you to take a look at their personal experiences of living with epilepsy and their hopes for the future.
New EU project CORONET
Interfaces between the brain and electrical circuits in technical devices or computers open new perspectives for basic research and medical application, e.g., for therapeutic brain stimulation and neuroprosthetics. The new EU project CORONET will develop the technological and theoretical foundations for such future “bio-hybrid” interfaces between biological and artificial nervous tissues.
An improved view with 64 slices
Late in 2009, GE Healthcare’s 64 slice PET/CT Discovery 690 began its use in the University Clinic for Nuclear Medicine in Innsbruck, Austria. Apart from routine clinical examinations for treatment control via FDG (fluorodeoxyglucose), the scanner is also employed in clinical research - particularly for Gallium 68DOTA PET/CT examination.
When is our hand not our hand?
When we look at our hands, how do we know they are part of our body? This seems like a strange question because it is something most of us take for granted. Exciting new data from a research group at the Karolinska Institutet in Sweden show that the brain uses a combination of sensory signals from our eyes and limbs to achieve a sense of ‘body ownership’.
The ultra-high-field MRI symposium
Early problems of ultra-high field Magnetic Resonance Imaging (MRI) have been overcome by successful development of adequate hardware. In consequence big efforts have been achieved in structural imaging, as well in functional imaging. Basic scientists and physicians who work in ultra-high-field MRI in Europe and the USA, met at the Berlin Ultra-high-field Facility (BUFF), in the Max Dehlbrück…
SECARS microscopy – a window to the world of molecules
SECARS microscopy, a procedure which is based on quantum effects, with which certain molecules can be monitored virtually in real time, turns out to be a highly sensitive tool for the non-invasive research of the most varied diseases and may supplement the medical diagnosis tools of CT and MRI in the future.
Neurological diseases on the rise
„Diseases of the nervous system and the brain occur more frequently than cancer. According to recent calculations of health care costs, they represent a burden of 386 billion euros a year on European economies,“ says Prof. Gérard Said, newly elected president of the European Neurological Society (ENS) at the annual meeting in Berlin, Germany. „This is often greatly underestimated.“
Peripheral nerve surgery
Neurosurgery has seen enormous progress, which should benefit as many patients as possible. However, according to Prof. Hanno Millesi MD, director of the Millesi Centre for Surgery of Peripheral Nerves, Wiener PrivatKlinik (WPK), a private hospital in Vienna, Austria, ‘methods are perceived incorrectly, because they are often confused with problematic predecessors, and sensible methods are…
The MR-guided intra-operative surgical suite
Intra-operative MR imaging is still uncommon in Europe – particularly in neurosurgery. One of the first neurosurgery departments to work with a 3-T MR is in the Central Military Hospital in Prague. The experience and initial clinical findings from treating more than 300 patients, over a two-year period, was reported at this year’s ECR.
Image processing - highlighting probabilities and possiblities
2010 workshop in Aachen, Germany, in March, were welcomed by Professor Thomas M Deserno, head of the Medical Informatics Department at RWTH Aachen University and organiser of what turned out to be an ‘outstanding’ scientific programme.
Catching Multiple Sclerosis before it strikes
More than 2 million over the world suffer from Multiple sclerosis (MS). It attacks the central nervous system and eventually renders most patients disabled. Although there is currently no cure, a breakthrough finding from a Tel Aviv University scientist and physician may lead to earlier diagnosis, more effective intervention, and perhaps even a cure for the autoimmune disease.
Article • Diagnosis, Management, Treatment
EPDA Champions Change for People with Parkinson’s Disease in Europe
To mark the first European Parkinson’s Action Day on April 12th, the European Parkinson’s Disease Association (EPDA) announced the launch of a major new investigation into the care of people with Parkinson’s across 36 European countries. Parkinson’s disease is the second most common progressive neurodegenerative condition which affects people from all around the world.
Neuroimaging Technique Identifies Patients at Risk for Alzheimer’s Disease in Healthy Brains
How the brain changes with age is not well-characterized and even less is known about the factors influencing the rate of brain aging. Brain imaging can offer a window into risk assessment into for diseases such as Alzheimer’s disease. A recent study demonstrated that genetic risk is expressed in the brains of even those who are healthy, but carry some risk for AD.
Quick accurate cervical cancer test
The United Kingdom has a strong medical devices industry; more than 2,000 companies employ over 50,000 people and support the employment of many more in this field. About 200 of these medical manufacturers are at Medica this year, at various pavilions, including those representing Wales, Scotland and Northern Ireland. Among the UK exhibitors, Zilico Ltd is presenting, for the first time, a…
Parkinson's Disease: genetic risk factors identified
Two genes containing mutations known to cause rare familial forms of parkinsonism are also associated with the more common, sporadic form of the disease where there is no family history, researchers have found. An International study reveals common gene variants in people of European descent.
11.7-T scanner a magnet to draw international researchers to France
A massive scanner for in vivo molecular imaging of the human brain will reveal the metabolic processes of neurological disorders, John Brosky reports
Carl Zeiss Speeds brain mapping and 3-D reconstruction
Electron microscopy and analysis instruments from Carl Zeiss are redefining the science of brain mapping and 3-D reconstruction. Wide-field, high resolution imaging, huge data storage and manipulation capabilities plus highly automated sample preparation techniques are yielding research results 100-times, or more, faster than ever before.
Schlaganfall-Therapie 24 Stunden am Tag
Patienten mit Schlaganfall erreichen die Klinik in der Regel zu spät. Vor allem wenn die Symptome am Sonntag einsetzen und relativ gering ausgeprägt sind, zögern die Angehörigen oftmals zu lange. Ohne Grund, wie eine aktuelle Auswertung des hessischen Schlaganfallregisters zeigt: Die Patienten erhielten auch am Wochenende und in den Nachtstunden eine qualitativ hochwertige Behandlung. Die…
Bayer presents positive Phase II data with florbetaben
Bayer Schering Pharma AG, Germany, has presented positive data on a global Phase II study with the novel positron emission tomography (PET) tracer florbetaben (BAY 94-9172) at the International Conference on Alzheimer's Disease (ICAD) in Vienna, Austria. This study showed that patients with a clinical diagnosis of Alzheimer´s disease could be differentiated from age-matched healthy volunteers…
Robotics and upper limb rehabilitation after strokes
In many ways the brain works like a hard disk. If the plug is pulled, important data is damaged and the system has to be rebooted.
Research project @neurIST tackles cerebral aneurysms
When a cerebral aneurysm ruptures, mortality is high and survivors often suffer stroke-like long-term disabilities. However, some aneurysms remain stable and never rupture. Surgical and endovascular interventions are possible, but not without risk.